Angle Is Ready To Capitalize On Promise Of Capture Cell Technology

Angle PLC has published half year interim results which indicate it will capitalize on a new liquid biopsy market.

Angle's Parsortix system • Source: Angle PLC

More from In Vitro Diagnostics

More from Diagnostics